UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000040463
Receipt No. R000046182
Scientific Title Comparison of the efficacy of TAPA block and TAP block for laparoscopic cholecystectomy
Date of disclosure of the study information 2020/06/10
Last modified on 2021/06/22 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Comparison of the efficacy of TAPA block and TAP block for laparoscopic cholecystectomy
Acronym Comparison of the efficacy of TAPA block and TAP block for laparoscopic cholecystectomy
Scientific Title Comparison of the efficacy of TAPA block and TAP block for laparoscopic cholecystectomy
Scientific Title:Acronym Comparison of the efficacy of TAPA block and TAP block for laparoscopic cholecystectomy
Region
Japan

Condition
Condition gallstone disease
Acute cholestasis
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Although TAP block has been widely used in laparoscopic cholecystectomy, comprehensive analgesia of the wound is difficult to achieve with TAP block alone. For this reason, postoperative analgesia is provided with narcotics and NSAIDs. However, although the TAPA block reported in 2019 has only been reported in case reports, it is said to be capable of providing total abdominal analgesia. In addition, the TAPA block requires fewer punctures and reduces the number of puncture-related complications. To date, there have been no prospective studies on the analgesic effect of TAPA block, and in this study, we will compare the efficacy of TAPA block and TAP block for laparoscopic cholecystectomy by conducting a randomized controlled trial.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Amount of opioids administered for analgesic purposes within 24 hours postoperatively
Key secondary outcomes NRS up to 24 hours postoperatively
Presence of side effects

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification YES
Dynamic allocation
Institution consideration
Blocking
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 TAPA block
Interventions/Control_2 TAP block
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients over 20 years of age undergoing laparoscopic cholecystectomy at the operating room of Juntendo University Shizuoka Hospital
Key exclusion criteria (1) Patients with bronchial asthma
(2) Patients with impaired renal function (eGFR<30)
(3) Patients who have been converted to open abdominal surgery
(4) Patients with unsuitable skin lesions at the puncture site
(5) Patients who have a history of allergy to local anesthetics
(6) Patients for whom the procedure is considered dangerous
(7) Other patients deemed unsuitable as subjects by the investigators.
Target sample size 34

Research contact person
Name of lead principal investigator
1st name shuhei
Middle name
Last name yonemoto
Organization Juntendo University Shizuoka hospital
Division name anesthesiology
Zip code 410-2295
Address 1129 Nagaoka Izunokuni-city Shizuoka, Japan
TEL 055-948-3111
Email s-yonemoto@juntendo.ac.jp

Public contact
Name of contact person
1st name shuhei
Middle name
Last name yonemoto
Organization Juntendo University Shizuoka hospital
Division name anesthesiology
Zip code 410-2295
Address 1129 Nagaoka Izunokuni-city Shizuoka, Japan
TEL 055-948-3111
Homepage URL
Email s-yonemoto@juntendo.ac.jp

Sponsor
Institute Juntendo University Shizuoka hospital
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Juntendo University Shizuoka hospital
Address 1129 Nagaoka Izunokuni-city Shizuoka, Japan
Tel 055-948-3111
Email s-yonemoto@juntendo.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2020 Year 06 Month 02 Day
Date of IRB
2020 Year 06 Month 10 Day
Anticipated trial start date
2020 Year 06 Month 15 Day
Last follow-up date
2022 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 05 Month 20 Day
Last modified on
2021 Year 06 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046182